Forodesine
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Forodesine, covering 2010-03-31 to 2017-05-11. Get the full timeline:
Most recent: Clinical Trial Update: Phase I/II Clinical Study of Forodesine in Japanese Recurrent/Refractory Peripheral T-cell Lymphoma Patients [Phase 1, Phase 2]